Mylan launches Hulio biosimilar in major European markets

Mylan-logoGlobal pharmaceutical company Mylan announced it has initiated the commercial launch of Hulio, a biosimilar to AbbVie’s Humira (adalimumab), across major markets in Europe. The product, which is approved for all adalimumab indications, will be available to patients as soon as possible.

Mylan president Rajiv Malik comments: ‘We’re proud of our strategic partnership with Fujifilm Kyowa Kirin Biologics and the strong collaboration of our science and technology teams to bring Hulio to market for patients. As the cost of healthcare continues to rise around the world, we know the important role that biosimilars play to ensure patients can access the medicines they need. The availability of Hulio, the fourth product in the area of complex generics and biosimilars that Mylan is bringing to market in Europe, will positively impact the lives of patients in Europe suffering from chronic diseases such as autoimmune disorders. We look forward to continuing our leadership in bringing high quality, more affordable biosimilar products to market around the world.’

 

Partnership promotes access to medicines

 

‘The availability of Hulio in Europe represents an important milestone, signifying our commitment to building and executing on robust scientific programs around our portfolio of biosimilar products in development,’ says Dr. Yoshifumi Torii, Fujifilm Kyowa Kirin Biologics president and CEO. ‘We are delighted by our partnership with Mylan to bring this important product to market in Europe.’

Mylan and Fujifilm Kyowa Kirin Biologics partnered earlier this year. Fujifilm Kyowa Kirin Biologics has a nonexclusive royalty bearing license with AbbVie (Mylan has a sublicense) for the use and sale of Hulio in European countries. The European Commission (EC) approved Hulio in September 2018, following the adoption of a positive opinion by the Committee for Medicinal Products for Human Use (CHMP), which concluded that the development program including analytical, functional, clinical and immunogenicity data demonstrated biosimilarity with Humira.

The EC approval of Hulio applies to all 28 European Union (EU) member countries and European Economic Area (EEA) member states of Norway, Iceland and Liechtenstein.

Hulio is indicated for the same indications of Humira, including:

Adults

  • Rheumatoid arthritis
  • Ankylosing spondylitis
  • Axial spondyloarthritis without radiographic evidence of ankylosing spondylitis
  • Psoriatic arthritis
  • Psoriasis
  • Hidradenitis suppurativa
  • Crohn’s disease
  • Ulcerative colitis
  • Uveitis

Children

  • Polyarticular juvenile idiopathic arthritis (age two and older)
  • Enthesitis-related arthritis (age six and older)
  • Plaque psoriasis (age four and older)
  • Crohn’s disease (age six and older)
  • Hidradenitis suppurativa (age 12 and older)
  • Uveitis (age two and older)

Humira is the world’s best-selling biologic medication. It had brand sales of approximately $4.3 billion in Europe for the 12 months ending 31 July 2018, according to IQVIA.



Latest


02 Aug 2021
dr.dermal targets pigmentation with new MelaBright IntensiveA

dr.dermal is proud to announce an innovative addition to its supplemental range of skin care products, with the launch of…

dr.dermal targets pigmentation with new MelaBright IntensiveA

dr.dermal is proud to announce an innovative addition to its supplemental range of skin care products, with the launch of MelaBright IntensiveA. According to dr.dermal, uneven skin tone and pigmentation are the most common concerns of clients. To address these concerns, dr.dermal’s passionate team of skin care professionals developed MelaBright…

02 Aug 2021
Maximise the natural content in your formulas with solutions from CJP Chemicals

The demand for environmentally friendly, clean and vegan beauty and personal care products places suppliers of natural, sustainable and traceable…

Maximise the natural content in your formulas with solutions from CJP Chemicals

The demand for environmentally friendly, clean and vegan beauty and personal care products places suppliers of natural, sustainable and traceable ingredients in the spotlight as more and more brands look to capture a share of this growing market. CJP Chemicals, an importer and supplier of raw materials and ingredients for…

29 Jul 2021
Symrise develops sustainable and biodegradable lily of the valley fragrance ingredient

Symrise has developed a special fragrance raw material from renewable sources. Lilybelle is a lily of the valley fragrance ingredient…

Symrise develops sustainable and biodegradable lily of the valley fragrance ingredient

Symrise has developed a special fragrance raw material from renewable sources. Lilybelle is a lily of the valley fragrance ingredient with a refreshingly flowery note. It will provide perfumers with novel possibilities for the creation of scents for personal care products, cleaning products and laundry care products. Symrise manufactures Lilybelle…

28 Jul 2021
SereinFormulas shampoo bars – good for people and the planet

Born to fundamentally shift customer expectations of an eco-friendly product, SereinFormulas provides a product that is more than just holistic.…

SereinFormulas shampoo bars – good for people and the planet

Born to fundamentally shift customer expectations of an eco-friendly product, SereinFormulas provides a product that is more than just holistic. We ultimately deliver a truly world-class product. Every ingredient in each of the brand’s shampoo bars is there for a specific value-added purpose. The goal is to make the eco-friendly…


Top stories


23 Apr 2020
Are you South Africa’s best female entrepreneur?

Entries are now open for the Santam Women of the Future Awards 2020 in association with Fairlady and True Love.…

Are you South Africa’s best female entrepreneur?

Entries are now open for the Santam Women of the Future Awards 2020 in association with Fairlady and True Love. Santam, Fairlady and, for the first time this year, Truelove Magazine, have partnered up in the search to find the best female entrepreneurs in the country. Best women entrepreneurs If…

30 Nov 2017
Rooibos could reduce risk of “Type 3” diabetes – a precursor to Alzheimer’s

Researchers at Warren Alpert Medical School at Brown University in the US found a link between a relatively new form…

Rooibos could reduce risk of “Type 3” diabetes – a precursor to Alzheimer’s

Researchers at Warren Alpert Medical School at Brown University in the US found a link between a relatively new form of diabetes, known as “type 3” diabetes and Alzheimer’s disease.

25 Jun 2020
How to ensure business agility in a pandemic

BY: Neil Birch, CEO at Novus Holdings Business agility is the capability of a business to respond quickly to a…

How to ensure business agility in a pandemic

BY: Neil Birch, CEO at Novus Holdings Business agility is the capability of a business to respond quickly to a changing environment, whether it be internal or external. Qualities of agile businesses include being adaptive, flexible and creative in your response to change without losing momentum (remaining productive) or vision.…

01 May 2020
Fibertex manufactures critical components for COVID-19 PPE

Fibertex SA, part of the global Fibertex Nonwovens group, has developed versatile high-performance components for protective facemasks and respirators. “Fibertex,…

Fibertex manufactures critical components for COVID-19 PPE

Fibertex SA, part of the global Fibertex Nonwovens group, has developed versatile high-performance components for protective facemasks and respirators. “Fibertex, which continuously invests in technological advancements to meet requirements in diverse industries – has increased production capacity of materials so desperately needed during the global COVID-19 pandemic,” explains Rosa Naidoo,…


Visit the official COVID-19 government website to stay informed: sacoronavirus.co.za